Abdera Therapeutics
Bernd O. Keller is an accomplished analytical chemist with extensive experience in both academia and industry. Currently serving as Principal Scientist at Abdera Therapeutics since December 2022, Bernd previously held positions as Senior Scientist in Analytical Chemistry and worked as a self-employed consultant from 2015 to 2022. Career highlights include a role as Senior Research Scientist at Numinus Bioscience and various academic positions at The University of British Columbia, Queen's University, and the University of Alberta, including Laboratory Coordinator at the Alberta Cancer Board Proteomics Centre. Bernd earned a Ph.D. in Analytical Chemistry from the University of Alberta and holds a Dipl. Ing. from Reutlingen University. Areas of expertise include advanced analytical technologies with a focus on pesticide analysis in complex matrices.